Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
Sponsor: Prabesh Kanel
Summary
This research is studying a supplement called tributyrin in people with Progressive Supranuclear Palsy (PSP) to learn about its safety and tolerability as a potential treatment. The goal of this research study is to see if a similar supplementation regimen and virtual testing is feasible for people with PSP.
Official title: Tributyrin for PSP: Phase 1b Virtual Trial - Feasibility Study
Key Details
Gender
All
Age Range
45 Years - Any
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2026-09
Completion Date
2027-05
Last Updated
2026-10-07
Healthy Volunteers
No
Interventions
Tributyrin
Post-biotic short chain fatty acid dietary supplement. Participants will take 500mg TID tributyrin supplement for 90 days +/- 7 days.
Placebo
Participants will take 500mg TID placebo for 90 days +/- 7 days.
Locations (1)
Domino's Farms
Ann Arbor, Michigan, United States